Analystreport

BioScrip Inc (NASDAQ: BIOS) had its "buy" rating re-affirmed by analysts at Craig Hallum. They now have a $3.50 price target on the stock.

BioPlus Acquisition Corp.  (BIOS) 
Last bioplus acquisition corp. earnings: 11/6 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: bioscrip.com/investors